SCHEMBL7685

SCHEMBL7685

O=C(OC(C(=O)O)C(OC(=O)c1ccccc1)C(=O)O)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 1.00
TP53 P04637 1/20 1.00
CYP2D6 P10635 2/20 0.65
RECQL P46063 1/20 0.61
LMNA P02545 2/20 0.56
F2 P00734 1/20 0.56
PDCD1 Q15116 1/20 0.50
CD274 Q9NZQ7 1/20 0.50
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
ALDH1A1 P00352 4/20 0.48
NPC1 O15118 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA3 P07451 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14117921 1.00 TSHR (1.00) TSHRTP53CYP2D6RECQLLMNA
SCHEMBL221678 1.00 TSHR (1.00) TSHRTP53CYP2D6RECQLLMNA
SCHEMBL11886503 1.00 TSHR (1.00) TSHRTP53CYP2D6RECQLLMNA
SCHEMBL223030 1.00 TSHR (1.00) TSHRTP53CYP2D6RECQLLMNA
SCHEMBL670257 1.00 TSHR (1.00) TSHRTP53CYP2D6RECQLLMNA
Ammonia Solution, Strong SCHEMBL11444695 0.98 TSHR (0.96) TSHRTP53CYP2D6RECQLLMNA
SCHEMBL28150719 0.98 TSHR (0.96) TSHRTP53CYP2D6RECQLLMNA
Water SCHEMBL312080 0.98 TSHR (0.96) TSHRTP53CYP2D6RECQLLMNA
Water SCHEMBL365251 0.98 TSHR (0.96) TSHRTP53CYP2D6RECQLLMNA
SCHEMBL28149702 0.98 TSHR (0.96) TSHRTP53CYP2D6RECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 17891 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103747-A1 SALT OF THIAZOLE DERIVATIVE INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF 江苏豪森药业集团有限公司 2026-05-21 WO claimed
US-12630520-B2 Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2026-05-19 US claimed
CN-122036704-A Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof 江苏豪森药业集团有限公司 2026-05-15 CN claimed
EP-3210965-B2 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUENENTHAL GMBH (DE) 2026-05-13 EP claimed
US-12624050-B2 Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2026-05-12 US claimed
EP-2556187-B1 ORGANIC-INORGANIC HYBRID NANOFIBRES HAVING A MESOPOROUS INORGANIC PHASE, PREPARATION THEREOF BY ELECTRICALLY ASSISTED EXTRUSION, MEMBRANE, ELECTRODE AND FUEL CELL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2026-05-06 EP claimed
WO-2026086809-A1 PROCESS FOR PREPARING 3- [ (3AS, 6AR) -5- {5-CHLORO-2- [ (1-METHYL-1H-PYRAZOL-4-YL) AMINO] PYRIMIDIN-4-YL} -3A-METHYL-OCTAHYDROPYRROLO [3, 4-C] PYRROLE-2-YL] -3-OXOPROPIONITRILE BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2026-04-30 WO claimed
EP-4721739-A1 CSF-1R INHIBITOR PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2026-04-08 EP claimed
EP-4265604-B1 OXASPIRO SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVE, INTERMEDIATE THEREOF, AND PREPARATION METHOD THEREFOR SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD (CN) 2026-04-01 EP claimed
CN-121586715-A Salt and crystal forms of methionine adenosine transferase 2A heterocyclic inhibitor and preparation method thereof 南京正大天晴制药有限公司 2026-02-27 CN claimed
EP-0082364-B1 (+)-2-(1-(2,6-DICHLOROPHENOXY)-ETHYL)-1,3-DIAZACYCLOPENT-2-ENE, PROCESS FOR ITS PREPARATION AND ITS USE IN PHARMACEUTICAL COMPOSITIONS A. Nattermann & Cie. GmbH (DE) 1986-04-23 EP claimed
EP-0015514-B1 OPTICALLY ACTIVE TERTIARY PHOSPHINES, PROCESS FOR THEIR PREPARATION AND USE FOR ASYMMETRICAL SYNTHESES BASF Aktiengesellschaft (DE) 1985-06-26 EP claimed
EP-0146155-A1 Ether of N-propanolamine derivative AKZO N.V. (NL) 1985-06-26 EP claimed
EP-0141408-A2 Process for the preparation of L(-)carnitine hydrochloride and of L(-)carnitine inner salt ISOM S.p.A. (IT) 1985-05-15 EP claimed
EP-0029175-B1 PROCESS FOR THE OBTENTION OF THE ENANTIOMERIC FORMS OF 4-CYANE-1-(N-METHYL-N-(2'-((3\",4\"-DIMETHOXYPHENYL))ETHYL-AMINO)-5-METHYL-4-(3',4',5'-TRIMETHOXYPHENYL) HEXANE AND ITS SALTS BASF Aktiengesellschaft (DE) 1982-12-15 EP claimed
US-4306082-A Optically active tertiary phosphine oxides and tertiary phosphines and processes for their preparation BASF AKTIENGESELLSCHAFT (DE) 1981-12-15 US claimed
US-4294838-A ANTIBRONCHOSPASMOLYTIC AGENTS WARNER-LAMBERT COMPANY, A CORP. OF DE 1981-10-13 US claimed
US-4183865-A SALT FORMATION WITH (-)DIBENZOYL TARTARIC ACID IN A POLAR SOLVENT KRKA, FARMACEVTIKA, KEMIJA, KOZMETIKA, ZDRAVILISCA IN GOSTINSTVO, NOVO MESTO, N.SOL.O. (YU) 1980-01-15 US claimed
US-4072698-A OPTICALLY ACTIVE ACIDS WITH KETONE OR ALDEHYDE CATALYST THE UPJOHN COMPANY (US) 1978-02-07 US claimed
US-4024082-A DL-N-CYCLOPROPYLMETHYL-3-HYDROXY-9-AZAMORPHINAN BRISTOL-MYERS COMPANY (US) 1977-05-17 US claimed